
SMS Lifesciences India Limited – NSE:SMSLIFE.NS
SMS Lifesciences India Limited stock price today
SMS Lifesciences India Limited stock price monthly change
SMS Lifesciences India Limited stock price quarterly change
SMS Lifesciences India Limited stock price yearly change
SMS Lifesciences India Limited key metrics
Market Cap | 3.63B |
Enterprise value | 4.55B |
P/E | 16.59 |
EV/Sales | 1.36 |
EV/EBITDA | 9.12 |
Price/Sales | 1.09 |
Price/Book | 1.93 |
PEG ratio | 0.41 |
EPS | 30.03 |
Revenue | 3.05B |
EBITDA | 319.96M |
Income | 90.79M |
Revenue Q/Q | 41.20% |
Revenue Y/Y | -3.04% |
Profit margin | 6.57% |
Oper. margin | 10.95% |
Gross margin | 19.77% |
EBIT margin | 10.95% |
EBITDA margin | 10.46% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSMS Lifesciences India Limited stock price history
SMS Lifesciences India Limited stock forecast
SMS Lifesciences India Limited financial statements
Jun 2023 | 746.51M | -17.95M | -2.4% |
---|---|---|---|
Sep 2023 | 692.61M | 6.66M | 0.96% |
Dec 2023 | 720.53M | 43.04M | 5.97% |
Mar 2024 | 899.91M | 59.04M | 6.56% |
Payout ratio | 0% |
---|
2016 | |
---|---|
2017 | |
2019 | 0.84% |
2020 | 1.01% |
2022 | 0.21% |
Jun 2023 | 0 | 0 | |
---|---|---|---|
Sep 2023 | 3339962000 | 1.66B | 49.87% |
Dec 2023 | 0 | 0 | |
Mar 2024 | 3905193000 | 1.96B | 50.42% |
Mar 2023 | 58.48M | 0 | 0 |
---|---|---|---|
Jun 2023 | 73.91M | 0 | 0 |
Sep 2023 | 74.68M | 0 | 0 |
Dec 2023 | 74.51M | 0 | 0 |
SMS Lifesciences India Limited alternative data
Aug 2023 | 565 |
---|---|
Sep 2023 | 565 |
Oct 2023 | 567 |
Nov 2023 | 567 |
Dec 2023 | 567 |
Jan 2024 | 567 |
Feb 2024 | 567 |
Mar 2024 | 567 |
Apr 2024 | 567 |
May 2024 | 567 |
Jun 2024 | 567 |
Jul 2024 | 567 |
SMS Lifesciences India Limited other data
-
What's the price of SMS Lifesciences India Limited stock today?
One share of SMS Lifesciences India Limited stock can currently be purchased for approximately $736.4.
-
When is SMS Lifesciences India Limited's next earnings date?
Unfortunately, SMS Lifesciences India Limited's (SMSLIFE.NS) next earnings date is currently unknown.
-
Does SMS Lifesciences India Limited pay dividends?
Yes, SMS Lifesciences India Limited pays dividends and its trailing 12-month yield is 0.12% with 0% payout ratio. The last SMS Lifesciences India Limited stock dividend of $0 was paid on 6 Sep 2025.
-
How much money does SMS Lifesciences India Limited make?
SMS Lifesciences India Limited has a market capitalization of 3.63B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11.9% to 3.06B US dollars.
-
What is SMS Lifesciences India Limited's stock symbol?
SMS Lifesciences India Limited is traded on the NSE under the ticker symbol "SMSLIFE.NS".
-
What is SMS Lifesciences India Limited's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of SMS Lifesciences India Limited?
Shares of SMS Lifesciences India Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does SMS Lifesciences India Limited have?
As Jul 2024, SMS Lifesciences India Limited employs 567 workers.
-
When SMS Lifesciences India Limited went public?
SMS Lifesciences India Limited is publicly traded company for more then 8 years since IPO on 18 Aug 2017.
-
What is SMS Lifesciences India Limited's official website?
The official website for SMS Lifesciences India Limited is smslife.in.
-
How can i contact SMS Lifesciences India Limited?
SMS Lifesciences India Limited can be reached via phone at +91 40 6628 8888.
SMS Lifesciences India Limited company profile:

SMS Lifesciences India Limited
smslife.inNSE
574
Biotechnology
Healthcare
SMS Lifesciences India Limited manufactures, buys, imports, and sells active pharmaceutical ingredients (API) and its intermediates, organic and inorganic chemicals, and pharmaceuticals in India. The company offers APIs in various therapeutic areas, such as antiulcer, antifungal, and erectile dysfunction. It also provides consultancy services. The company exports its products. The company was founded in 1990 and is based in Hyderabad, India.
Hyderabad, 500096
:
ISIN: INE320X01016
CUSIP: Y806HA102